Pfizer Continues To Funnel Capital Into Mission Therapeutics

Drug discovery and development company Mission Therapeutics has received another substantial investment from Pfizer’s VC arm, Pfizer Ventures. The British biotech company has been backed by Pfizer since 2013, primarily because of its novel work in selectively inhibiting deubiquitylating enzymes (DUBs)...